Annual Current Assets
$616.77 M
+$130.34 M+26.79%
31 December 2023
Summary:
Travere Therapeutics annual total current assets is currently $616.77 million, with the most recent change of +$130.34 million (+26.79%) on 31 December 2023. During the last 3 years, it has risen by +$206.37 million (+50.28%). TVTX annual current assets is now at all-time high.TVTX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$324.74 M
-$44.24 M-11.99%
30 September 2024
Summary:
Travere Therapeutics quarterly total current assets is currently $324.74 million, with the most recent change of -$44.24 million (-11.99%) on 30 September 2024. Over the past year, it has dropped by -$361.49 million (-52.68%). TVTX quarterly current assets is now -52.68% below its all-time high of $686.23 million, reached on 30 September 2023.TVTX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TVTX Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +26.8% | -52.7% |
3 y3 years | +50.3% | -43.9% |
5 y5 years | +24.4% | -26.1% |
TVTX Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +50.3% | -52.7% | at low |
5 y | 5 years | at high | +50.3% | -52.7% | at low |
alltime | all time | at high | >+9999.0% | -52.7% | >+9999.0% |
Travere Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $324.74 M(-12.0%) |
June 2024 | - | $368.98 M(-23.3%) |
Mar 2024 | - | $481.08 M(-22.0%) |
Dec 2023 | $172.14 M(-7.5%) | $616.77 M(-10.1%) |
Sept 2023 | - | $686.23 M(+26.6%) |
June 2023 | - | $542.05 M(-10.4%) |
Mar 2023 | - | $604.90 M(+24.4%) |
Dec 2022 | $186.11 M(-4.0%) | $486.44 M(-9.1%) |
Sept 2022 | - | $534.84 M(-8.9%) |
June 2022 | - | $586.78 M(-7.0%) |
Mar 2022 | - | $631.09 M(+8.3%) |
Dec 2021 | $193.77 M(-1.7%) | $582.83 M(+0.6%) |
Sept 2021 | - | $579.08 M(+5.3%) |
June 2021 | - | $549.80 M(-2.7%) |
Mar 2021 | - | $565.04 M(+37.7%) |
Dec 2020 | $197.03 M(+12.1%) | $410.41 M(-17.5%) |
Sept 2020 | - | $497.68 M(-1.6%) |
June 2020 | - | $505.56 M(+24.3%) |
Mar 2020 | - | $406.63 M(-5.2%) |
Dec 2019 | $175.74 M(-17.7%) | $429.06 M(-2.4%) |
Sept 2019 | - | $439.72 M(-3.8%) |
June 2019 | - | $457.01 M(-3.9%) |
Mar 2019 | - | $475.51 M(-4.1%) |
Dec 2018 | $213.48 M(+9.7%) | $495.68 M(-1.5%) |
Sept 2018 | - | $502.99 M(+80.3%) |
June 2018 | - | $278.92 M(-2.7%) |
Mar 2018 | - | $286.80 M(-12.0%) |
Dec 2017 | $194.54 M | $325.81 M(+0.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2017 | - | $325.34 M(+1.8%) |
June 2017 | - | $319.66 M(-0.8%) |
Mar 2017 | - | $322.40 M(-3.0%) |
Dec 2016 | $192.93 M(-8.3%) | $332.35 M(-3.0%) |
Sept 2016 | - | $342.59 M(+14.1%) |
June 2016 | - | $300.16 M(+0.8%) |
Mar 2016 | - | $297.74 M(-1.4%) |
Dec 2015 | $210.33 M(+114.3%) | $301.93 M(+0.7%) |
Sept 2015 | - | $299.95 M(+22.6%) |
June 2015 | - | $244.74 M(+4.8%) |
Mar 2015 | - | $233.54 M(+525.6%) |
Dec 2014 | $98.14 M(+655.0%) | $37.33 M(-17.8%) |
Sept 2014 | - | $45.44 M(-14.9%) |
June 2014 | - | $53.40 M(+728.8%) |
Mar 2014 | - | $6.44 M(-14.1%) |
Dec 2013 | $13.00 M(+451.2%) | $7.50 M(-55.5%) |
Sept 2013 | - | $16.85 M(+4066.1%) |
June 2013 | - | $404.40 K(-84.7%) |
Mar 2013 | - | $2.64 M(>+9900.0%) |
Dec 2012 | $2.36 M(>+9900.0%) | - |
Nov 2012 | - | $3900.00(0.0%) |
Aug 2012 | - | $3900.00(0.0%) |
May 2012 | - | $3900.00(0.0%) |
Feb 2012 | - | $3900.00(0.0%) |
Feb 2012 | $0.00(0.0%) | - |
Nov 2011 | - | $3900.00(0.0%) |
Aug 2011 | - | $3900.00(-2.5%) |
Feb 2011 | $0.00 | $4000.00 |
FAQ
- What is Travere Therapeutics annual total current assets?
- What is the all time high annual current assets for Travere Therapeutics?
- What is Travere Therapeutics annual current assets year-on-year change?
- What is Travere Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Travere Therapeutics?
- What is Travere Therapeutics quarterly current assets year-on-year change?
What is Travere Therapeutics annual total current assets?
The current annual current assets of TVTX is $616.77 M
What is the all time high annual current assets for Travere Therapeutics?
Travere Therapeutics all-time high annual total current assets is $616.77 M
What is Travere Therapeutics annual current assets year-on-year change?
Over the past year, TVTX annual total current assets has changed by +$130.34 M (+26.79%)
What is Travere Therapeutics quarterly total current assets?
The current quarterly current assets of TVTX is $324.74 M
What is the all time high quarterly current assets for Travere Therapeutics?
Travere Therapeutics all-time high quarterly total current assets is $686.23 M
What is Travere Therapeutics quarterly current assets year-on-year change?
Over the past year, TVTX quarterly total current assets has changed by -$361.49 M (-52.68%)